BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15096536)

  • 1. Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7.
    Lathem WW; Bergsbaken T; Welch RA
    J Exp Med; 2004 Apr; 199(8):1077-87. PubMed ID: 15096536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor.
    Lathem WW; Grys TE; Witowski SE; Torres AG; Kaper JB; Tarr PI; Welch RA
    Mol Microbiol; 2002 Jul; 45(2):277-88. PubMed ID: 12123444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the StcE protease activity of Escherichia coli O157:H7.
    Grys TE; Walters LL; Welch RA
    J Bacteriol; 2006 Jul; 188(13):4646-53. PubMed ID: 16788173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of stcE, a C1 esterase inhibitor-specific metalloprotease, during the evolution of Escherichia coli O157:H7.
    Lathem WW; Bergsbaken T; Witowski SE; Perna NT; Welch RA
    J Infect Dis; 2003 Jun; 187(12):1907-14. PubMed ID: 12792867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells.
    Grys TE; Siegel MB; Lathem WW; Welch RA
    Infect Immun; 2005 Mar; 73(3):1295-303. PubMed ID: 15731026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional characterization of a ToxR-regulated lipoprotein from a clinical isolate of Aeromonas hydrophila.
    Pillai L; Sha J; Erova TE; Fadl AA; Khajanchi BK; Chopra AK
    Infect Immun; 2006 Jul; 74(7):3742-55. PubMed ID: 16790746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7.
    Szabady RL; Lokuta MA; Walters KB; Huttenlocher A; Welch RA
    PLoS Pathog; 2009 Feb; 5(2):e1000320. PubMed ID: 19247439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
    Levy NJ; Kasper DL
    J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.
    Wijeyewickrema LC; Lameignere E; Hor L; Duncan RC; Shiba T; Travers RJ; Kapopara PR; Lei V; Smith SA; Kim H; Morrissey JH; Pike RN; Conway EM
    Blood; 2016 Sep; 128(13):1766-76. PubMed ID: 27338096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement 1 inhibitor is a regulator of the alternative complement pathway.
    Jiang H; Wagner E; Zhang H; Frank MM
    J Exp Med; 2001 Dec; 194(11):1609-16. PubMed ID: 11733575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma membrane profiling during enterohemorrhagic
    Furniss RCD; Low WW; Mavridou DAI; Dagley LF; Webb AI; Tate EW; Clements A
    J Biol Chem; 2018 Nov; 293(44):17188-17199. PubMed ID: 30190327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A postulated mechanism for heparin's potentiation of C1 inhibitor function.
    Caughman GB; Boackle RJ; Vesely J
    Mol Immunol; 1982 Feb; 19(2):287-95. PubMed ID: 7099168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.
    Jansen PM; Eisele B; de Jong IW; Chang A; Delvos U; Taylor FB; Hack CE
    J Immunol; 1998 Jan; 160(1):475-84. PubMed ID: 9552006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional aspects of C1-inhibitor.
    Bos IG; Hack CE; Abrahams JP
    Immunobiology; 2002 Sep; 205(4-5):518-33. PubMed ID: 12396012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood.
    Landsem A; Nielsen EW; Fure H; Christiansen D; Ludviksen JK; Lambris JD; Østerud B; Mollnes TE; Brekke OL
    Clin Exp Immunol; 2013 Aug; 173(2):217-29. PubMed ID: 23607270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.
    Poppelaars F; Damman J; de Vrij EL; Burgerhof JG; Saye J; Daha MR; Leuvenink HG; Uknis ME; Seelen MA
    Clin Exp Immunol; 2016 Jun; 184(3):378-88. PubMed ID: 26874675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of C1 inhibitor.
    Davis AE
    Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.